Product NDC: | 55154-5750 |
Proprietary Name: | Benzonatate |
Non Proprietary Name: | Benzonatate |
Active Ingredient(s): | 100 mg/1 & nbsp; Benzonatate |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55154-5750 |
Labeler Name: | Cardinal Health |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA081297 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101114 |
Package NDC: | 55154-5750-4 |
Package Description: | 100 POUCH in 1 CARTON (55154-5750-4) > 1 CAPSULE in 1 POUCH (55154-5750-6) |
NDC Code | 55154-5750-4 |
Proprietary Name | Benzonatate |
Package Description | 100 POUCH in 1 CARTON (55154-5750-4) > 1 CAPSULE in 1 POUCH (55154-5750-6) |
Product NDC | 55154-5750 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Benzonatate |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20101114 |
Marketing Category Name | ANDA |
Labeler Name | Cardinal Health |
Substance Name | BENZONATATE |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Decreased Tracheobronchial Stretch Receptor Activity [PE],Non-narcotic Antitussive [EPC] |